Chief Complaint Transplant Diagnosis : Acute myelogenous leukemia ( AML ) ( complex cytogentics refractory to chemotherapy ) . 
Date of Transplant : 5/6/2010 . 
Day Post - Transplant : 19 . 
Reason for admission : 5 / 3 for Cytoxan conditioning followed by PBSCT . 
Interval History Pt feeling well with increased energy , appetite . 
Tolerating soft foods well . 
Stool volume slightly increased , although pt reports stool frequency the same ; no urgency . 
Consistency loose , not liquid . . 
Pain Management mild mucositis pain well controlled , not using any oxycodone . 
magic mouthwash with good effect . . 
Patient Controlled Analgesics : Not applicable . 
Pain Management : oxycodone available PRN . 
Transplant Status PROTOCOL / TREATMENT PLAN : 739 / 1932 . 
TRANSPLANT TYPE allogeneic unrelated , matched peripheral blood stem cell transplant . 
CMV SEROLOGY Donor negative , Recipient negative . 
PREPARATIVE REGIMEN : Myeloablative TBI , cyclophosphamide . 
GVHD Prophylaxis Methotrexate , Tacrolimus . 
Allergies NKA Medications Medications reviewed on 5/25/2010 . 
Scheduled Medications Acyclovir 
800 mg tab Dose : 800 mg = 1 tab PO BID Amlodipine 5 mg tab Dose : 5 mg = 1 tab PO QDay Beclomethasone in oil ( conc 1 mg/mL ) Dose : 2 mg = 2 mL PO QID Budesonide 3 mg cap Dose : 3 mg = 1 cap PO TID Pantoprazole 40 mg tab Dose : 40 mg = 1 tab PO QDay Tacrolimus 1 mg cap + Tacrolimus 0 . 
5mg cap Dose : 1.5 mg PO Q12 Hours Ursodiol 300 mg cap Dose : 600 mg = 2 cap PO BID Vancomycin soln ( conc 50 mg/mL ) ( ORAL ) Dose : 125 mg = 2.5 mL PO QMWF Vancomycin soln ( conc 50 mg/mL ) ( ORAL ) Dose : 125 mg = 2.5 mL PO QAM Vancomycin soln ( conc 50 mg/mL ) ( ORAL ) Dose : 125 mg = 2.5 mL PO Q12 Hours Vitamin multi with minerals , no iron tab Dose : 1 tab PO QDay Voriconazole 200 mg tab + Voriconazole 50 mg tab Dose : 350 mg PO Q12 Hours Infusions 
No Infusion Medications Found . 
PRN Medications 
Boston butt cream 120 g Dose : 1 application Topical QDay PRN Cepacol ( or equivalent ) 
lozenge Dose : 1 lozenge Mucosal Q4 Hours PRN HydrALAZINE 20 mg/mL inj Dose : 10 mg = 0.5 mL IV Q4 Hours PRN 
Lidocaine / Diphenhydra / Al - Mg hydrox 180 mL Dose : 5 mL Swish & Spit Q4 Hours PRN Oxycodone 5 mg tab Dose : 5 - 10 mg PO Q4 Hours PRN Sodium chloride 0.65 % nasal spray 60 mL Dose : 1 spray ( s ) 
Each Nostril QDay PRN Review of Systems CONSTITUTIONAL Symptoms Denies fever . 
Denies chills . 
Denies malaise . 
Denies weakness . 
Denies sweats . 
ENMT Mucositis . 
Sinus congestion . 
. 
Denies rhinorrhea . 
Denies sore throat . 
CARDIOVASCULAR Symptoms Denies chest pain . 
Denies lightheadedness . 
Denies palpitations . 
Denies swelling . 
RESPIRATORY Symptoms Denies cough . 
Denies shortness of breath . 
GASTROINTESTINAL Symptoms soft , loose stools , improving in consistency . 
, denies abdominal pain , denies nausea , denies vomiting . 
GENITOURINARY Symptoms denies dysuria . 
MUSCULOSKELETAL Symptoms joint pain ( vague bilateral knee achiness ) . 
PSYCHIATRIC Symptoms negative . 
SKIN Symptoms denies rash . 
NEUROLOGIC Symptoms denies headaches , denies dizziness . 
HEME / LYMPH Symptoms denies bleeding . 
Physical Examination Vital Signs Vital Signs Data , 05/25/2010 
08:29 Temperature - C 36.2 degC Temperature Source Axillary Heart Rate 94 bpm Respiratory Rate 16 
br / min SBP - Noninvasive 109 mmHg DBP - Noninvasive 80 mmHg Oxygenation Data . 
05/25/2010 08:29 SpO2 97 % O2 
Delivery Device Room air I / O : . 
In ; 1160 Out : 2150 Stool 
: 550Weight : 
Height / Weight / BMI - General . 
05/25/2010 09:53 
DAILY Weight - kg 82.9 kg CONSTITUTIONAL : no apparent distress . 
MENTAL STATUS : alert and oriented x3 , Level of Consciousness : alert , normal mood / affect . 
EYES : pupils equal , round , reactive to light , extraocular movements intact , EOMI , normal sclera . 
EARS , NOSE , MOUTH , and THROAT : 
erythema with few white plaques on bilateral buccal mucosa , otherwise oropharynx clear with mild inflammation , faint erythema , no ulcerations . . 
MUCOSITIS ( WHO Oral Toxicity Scale ) : 
Grade 2 : Erythema and ulcers , patient can swallow solid diet . 
RESPIRATORY / CHEST : normal respiratory effort , Clear to auscultation . . 
CARDIOVASCULAR : regular rate and rhythm , no murmur , rub or gallop , no cyanosis or edema . 
GASTROINTESTINAL : normal , normal bowel sounds , abdomen non - tender , abdomen non - distended . 
MUSCULOSKELETAL : normal gait / stance , normal strength , tone and range of motion . 
SKIN : no rash , bruises or ulcers , right hickman line intact . 
no erythema , tenderness , inflammation . . 
Laboratory Studies Laboratory Studies ( Most recent results in 24 hour range . ) 
RESULTS FROM TODAY RESULTS FROM YESTERDAY 05/25/10 00:30 05/24/10 00:30 
| - ICa - - - | - ICa - - - 141 108 14 | - Ca 9.5 141 106 14 | - Ca 9.3 - - - - - - - - - | - - - - - - - - - - - - - | - - - - - - - - - - - - < 142 | - Mg 1.2 - - - - - - - - - | - - - - - - - - - - - - - | - - - - - - - - - - - - < 110 | - Mg 1.4 4.4 26 0.5 | - Phos - - - 4.4 25 0.5 | - Phos 5.5 RESULTS FROM TODAY RESULTS FROM YESTERDAY 05/25/10 00:30 05/24/10 00:30 10.4 | - PT - - - 10.5 | - PT - - - 4.40 ] - - - - - - - - - - - - - - - - - - - - - - [ 69 | - INR - - - 3.93 ] - - - - - - - - - - - - - - - - - - - - - - [ 55 | - INR - - - 30 | - PTT - - - 31 | - PTT - - - ( Most recent results for 24 hour range . ) 
Individual Labs 05/25/2010 00:30 
MCV 84 
05/25/2010 00:30 
Neutrophils 2.17 Antibiotics 
No Results Found . 
( Most Recent Results for Prior 7 Days . ) 
Immunosuppressant 05/24/2010 21:40 
Tacrolimus Level by LCMSMS 10 ( Most Recent Results for Prior 14 Days . ) 
CMV Results 
No Results Found . 
Viral / CMV Monitoring 
No results in the past 7 days . 
Radiological Studies 
Chest X - Ray : 5/18/10 Right internal jugular central venous catheter tip remains in the proximal SVC . 
The lungs are clear . 
No pneumothorax or pleural effusion . 
The heart size is normal and unchanged . 
Mild multilevel thoracic disc degeneration is present . 
No compression fractures . 
, 5/23/10 : Findings / Impression : Lungs clear . 
No pneumothorax is present . 
Right internal jugular catheter are stable . . 
Consult ( s ) 
Requested GI consult ordered : Date consult ordered : 5/20/10 , Evaluation of diarrhea , Rule out GVHD . 
Assessment / Plan PRIMARY DISEASE : 45 year old man with refractory AML with complex cytogenetics , now day 19 s/p MURD PBSCT with TBI / Cy conditioning . 
HEMATOLOGIC : 
platelet threshold : 10 thousand , Hematocrit threshold : 26 % , 
Now engrafted . 
Remains anemic and thrombocytopenic but blood counts climbing and no longer needing transfusion support . . 
INFECTIOUS DISEASE : 
Active VIRAL infection / Diagnosis date : Corona Virus 5/21/10 . 
Infection Prophylaxis : Antifungal agent ( s ) : 
Voriconazole , Antiviral agent ( s ) : Acyclovir . 
Plan : 1 . C . 
difficile . 
+ Cdiff from 5 / 5 ; history of recurrent Cdiff ( this is his third infection ) . 
Oral vancomycin started 5 / 5 ( dose increased on 5 / 7 to 500 mg PO q 6 hr ) ; PO Flagyl added 5 / 6 . 
Per ID recommendations , switched to IV Flagyl on 5 / 7 . 
Diarrhea significantly improved . 
Completed 10 - days of Flagyl on 5 / 16 . 
Vancomycin dose reduced to 250 mg PO q 6 hrs on 5 / 13 per ID recommendation . 
Will subsequently taper Vancomycin per taper schedule generated by Pharmacy . 
Diarrhea returned as of 5 / 19 , but unlikely infectious etiology as C diff from 5 / 19 negative . 
Now improving again . 2 . 
Resumed Voriconazole on 5 / 7 ( d +1 ) . 
No history of pulmonary nodules ; treatment is empiric and likely due to prolonged cytopenias . 
3 . 
Corona virus positive from 5 / 21 nasal wash PCR . 
Chest xray clear . 
Nasal congestion improving . . 
Active BACTERIAL infection 
/ Diagnosis date : C . 
diff 5 / 4 stool cx . 
PO Vancomycin start 5 / 5 ; PO Flagyl started 5 / 6 ; switched to IV Flagyl on 5 / 7 . . . 
DRUG MONITORING : 
Tacrolimus : decreased dose ( PO FK - 506 decreased to 1.5 mg PO q 12 hrs on 5 / 24 PM . ) . 
GRAFT - VERSUS - HOST 
DISEASE : 
Active LOWER GI GVHD Assessment : Diarrhea present Estimated 24 hour stool volume : 550 ml , Differential Diagnosis : 
GVHD , Conditioning regimen , Infection . 
Plan : Remains on Tacrolimus since 5 / 5 . 
Level elevated to 16 on 5 / 20 ; decreased dose then . 
Methotrexate given on D1 , 3 , 6 , 11 . 
New onset diarrhea on 5 / 19 , EGD / Flex Sig 5 / 20 . 
Started empiric beclothemasone and budesonide on 5 / 20 per GI recommendations . 
Most likely conditioning toxicity as he is making improvement but will continue to monitor closely . 
Final pathology suggestive of residual chemotherapy toxicity versus early GVHD . . 
REGIMEN RELATED TOXICITY : 
1 . Grade 4 Mucositis , resolving . 
No longer requiring TPN or PCA . 
Oral intake improving . . 
GASTROINTESTINAL : Diarrhea , stable and resolving . 
Repeat stool for C . 
diff negative by PCR . 
Stool for norovirus , rotavirus and adenovirus pending . 
Pathology results from 5 / 20 EGD / flex sig not conclusive and differential remains early gut GVHD vs . 
infection vs RRT . 
He does seem to be improving and will monitor for now . 
Acid reflux , remains on Protonix daily with good control of symptoms . . 
FLUIDS , ELECTROLYTES & NUTRITION : 
He is slowly starting to improve oral intake ; no further TPN . 
Medications now all oral formulation . 
Hypomagnesemia , requiring PRN repletion . . 
Comments Will monitor stool output / consistency closely . 
Plan to discharge to SCCA OPD on 5 / 26 if diarrhea stable and PO intake still good . 
Signature Kristen Kindsvogel , ARNP SCCA / FHCRC Bone Marrow Transplant Service 
